No consistent effect on refractive outcomes found when using a CTR

Article

Using a capsular tension ring (CTR) implantation has been found to have no consistent effect on refractive outcomes compared with routine phacoemulsification in highly myopic eyes.

Using a capsular tension ring (CTR) implantation has been found to have no consistent effect on refractive outcomes compared with routine phacoemulsification in highly myopic eyes, according to results published in the Journal of Cataract & Refractive Surgery.

Dr Andrea M. Schild et al., University of Cologne, Germany, examined the effect that CTR implantation has on refractive outcomes in patients with high myopia. The researchers drew comparisons between phacoemulsification, IOL implantation with a CTR (CTR group) and without a CTR (control group). Optical biometry was measured using the IOLMaster and the power of the IOL was used to calculate the predicted postoperative spherical equivalent using the Haigis and SRK/T formulas. The main outcomes were the mean error and mean absolute error of the refractive prediction error.

The results demonstrated that the CTR group mean axial length was 29.1 mm and the control group mean axial length was 28.2 mm. No statistically significant difference was noted in mean absolute refractive prediction error between the CTR group and the control group with either formula. However, it was found that there was lower variance in the absolute refractive prediction error in the CTR group with both formulas.

It was revealed that when using a CTR a higher precision in refractive outcomes was obtained and there was no need to alter the IOL power calculation. However, there was no consistent effect on refractive outcomes in highly myopic eyes when using a CTR implant in comparison with phacoemulsification.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.